<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CA3 Journal Club: PONV Prophylaxis</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script>
        tailwind.config = {
            theme: {
                extend: {
                    colors: {
                        'dark-bg': '#0f1419',
                        'dark-card': '#1a2332',
                        'dark-card-alt': '#1e2a3a',
                        'dark-border': '#2a3a4a',
                        'accent-teal': '#2dd4bf',
                        'accent-gold': '#fbbf24',
                        'accent-green': '#22c55e',
                        'accent-red': '#ef4444',
                        'text-primary': '#f1f5f9',
                        'text-secondary': '#94a3b8',
                        'text-muted': '#64748b'
                    }
                }
            }
        }
    </script>
    <style>
        @import url('https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap');

        * {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
        }

        body {
            background-color: #0f1419;
            min-height: 100vh;
        }

        .header-bg {
            background: linear-gradient(180deg, #0f1419 0%, #1a2332 100%);
            position: relative;
            overflow: hidden;
        }

        .header-bg::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            height: 200px;
            background: url("data:image/svg+xml,%3Csvg viewBox='0 0 1200 200' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='M0 100 Q300 50 600 100 T1200 100 V0 H0 Z' fill='%231a2332' opacity='0.5'/%3E%3C/svg%3E") no-repeat;
            background-size: cover;
            opacity: 0.6;
        }

        .card {
            background: #1a2332;
            border: 1px solid #2a3a4a;
            border-radius: 16px;
        }

        .card-alt {
            background: #1e2a3a;
            border: 1px solid #2a3a4a;
            border-radius: 12px;
        }

        .tab-btn {
            transition: all 0.3s ease;
            color: #64748b;
        }

        .tab-btn.active {
            color: #2dd4bf;
            border-bottom: 2px solid #2dd4bf;
        }

        .tab-btn:not(.active):hover {
            color: #94a3b8;
        }

        .tab-content {
            display: none;
            animation: fadeIn 0.3s ease;
        }

        .tab-content.active {
            display: block;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .stat-card {
            background: #1e2a3a;
            border: 1px solid #2a3a4a;
            border-radius: 12px;
            transition: transform 0.2s ease;
        }

        .stat-card:hover {
            transform: translateY(-2px);
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 4px 12px;
            border-radius: 9999px;
            font-size: 12px;
            font-weight: 500;
        }

        .badge-teal {
            background: rgba(45, 212, 191, 0.15);
            color: #2dd4bf;
            border: 1px solid rgba(45, 212, 191, 0.3);
        }

        .badge-gold {
            background: rgba(251, 191, 36, 0.15);
            color: #fbbf24;
            border: 1px solid rgba(251, 191, 36, 0.3);
        }

        .badge-green {
            background: rgba(34, 197, 94, 0.2);
            color: #22c55e;
        }

        .badge-gray {
            background: rgba(100, 116, 139, 0.2);
            color: #94a3b8;
        }

        .badge-dark {
            background: #2a3a4a;
            color: #94a3b8;
            font-size: 11px;
            padding: 4px 10px;
        }

        .study-card {
            background: #1a2332;
            border: 1px solid #2a3a4a;
            border-radius: 16px;
            overflow: hidden;
        }

        .outcome-box {
            background: #0f1419;
            border-radius: 12px;
            padding: 20px;
        }

        .quiz-option {
            transition: all 0.2s ease;
            cursor: pointer;
            background: #1e2a3a;
            border: 1px solid #2a3a4a;
        }

        .quiz-option:hover:not(.selected):not(.correct):not(.incorrect) {
            border-color: #2dd4bf;
            background: rgba(45, 212, 191, 0.1);
        }

        .quiz-option.selected {
            background: rgba(45, 212, 191, 0.15);
            border-color: #2dd4bf;
        }

        .quiz-option.correct {
            background: rgba(34, 197, 94, 0.15);
            border-color: #22c55e;
        }

        .quiz-option.incorrect {
            background: rgba(239, 68, 68, 0.15);
            border-color: #ef4444;
        }

        .pico-badge {
            width: 28px;
            height: 28px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 700;
            border-radius: 6px;
            flex-shrink: 0;
            font-size: 14px;
        }

        .reflection-textarea {
            min-height: 100px;
            transition: all 0.2s ease;
            background: #1e2a3a;
            border: 1px solid #2a3a4a;
            color: #f1f5f9;
        }

        .reflection-textarea:focus {
            border-color: #2dd4bf;
            outline: none;
            box-shadow: 0 0 0 3px rgba(45, 212, 191, 0.2);
        }

        .reflection-textarea::placeholder {
            color: #64748b;
        }

        .icon-circle {
            width: 40px;
            height: 40px;
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            flex-shrink: 0;
        }

        .number-badge {
            width: 28px;
            height: 28px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 600;
            font-size: 14px;
            flex-shrink: 0;
        }

        @media print {
            body { background: white; }
            .no-print { display: none !important; }
            .card, .card-alt, .study-card { background: #f8fafc; border: 1px solid #e2e8f0; }
        }
    </style>
</head>
<body class="text-text-primary">
<!-- Header -->
<header class="header-bg sticky top-0 z-50">
    <div class="max-w-6xl mx-auto px-4 py-6 relative z-10">
        <div class="flex items-center gap-3 mb-3">
            <span class="badge badge-teal">CA3 Journal Club</span>
            <span class="text-text-muted">‚Ä¢</span>
            <span class="text-text-secondary text-sm">Interactive Learning Module</span>
        </div>

        <h1 class="text-3xl md:text-4xl font-bold mb-2">
            <span class="text-white">PONV Prophylaxis</span>
            <span class="text-accent-gold"> & Multimodal Prevention</span>
        </h1>
        <p class="text-text-secondary text-sm md:text-base">
            Examining the evidence: Are antiemetic effects additive, and can we extrapolate to newer agents?
        </p>

        <!-- Tab Navigation -->
        <nav class="flex gap-6 mt-6 border-b border-dark-border overflow-x-auto no-print">
            <button class="tab-btn active px-1 py-3 text-sm font-medium whitespace-nowrap" data-tab="overview">
                Overview
            </button>
            <button class="tab-btn px-1 py-3 text-sm font-medium whitespace-nowrap" data-tab="apfel">
                Apfel et al.
            </button>
            <button class="tab-btn px-1 py-3 text-sm font-medium whitespace-nowrap" data-tab="grigio">
                Grigio et al.
            </button>
            <button class="tab-btn px-1 py-3 text-sm font-medium whitespace-nowrap" data-tab="discussion">
                Discussion Insights
            </button>
            <button class="tab-btn px-1 py-3 text-sm font-medium whitespace-nowrap" data-tab="quiz">
                Quiz
            </button>
        </nav>
    </div>
</header>

<main class="max-w-6xl mx-auto px-4 py-8">
    <!-- Overview Tab -->
    <div id="overview" class="tab-content active space-y-6">
        <!-- Central Question -->
        <section class="card p-6">
            <div class="flex items-start gap-4">
                <div class="icon-circle bg-accent-teal/20">
                    <svg class="w-5 h-5 text-accent-teal" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8.228 9c.549-1.165 2.03-2 3.772-2 2.21 0 4 1.343 4 3 0 1.4-1.278 2.575-3.006 2.907-.542.104-.994.54-.994 1.093m0 3h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                    </svg>
                </div>
                <div>
                    <h2 class="text-accent-teal font-semibold mb-2">The Central Question</h2>
                    <p class="text-xl md:text-2xl text-white leading-relaxed">
                        If the effects of antiemetics are <em class="text-accent-teal">additive</em>, can we extrapolate findings from classic antiemetics to newer agents like <span class="text-accent-gold">palonosetron</span> and <span class="text-accent-gold">aprepitant</span>?
                    </p>
                    <p class="text-text-muted mt-3 text-sm">
                        Consider: Is deep anesthesia a <em>cause</em> of delirium, or merely a <em>marker</em> of vulnerability?
                    </p>
                </div>
            </div>
        </section>

        <!-- Why This Matters -->
        <section class="card p-6">
            <div class="flex items-start gap-4 mb-6">
                <div class="icon-circle bg-accent-gold/20">
                    <svg class="w-5 h-5 text-accent-gold" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                        <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"></path>
                    </svg>
                </div>
                <div>
                    <h2 class="text-accent-gold font-semibold">Why This Matters to Anesthesiologists</h2>
                    <p class="text-text-secondary text-sm">Clinical relevance for your daily practice</p>
                </div>
            </div>

            <div class="grid md:grid-cols-3 gap-4 mb-6">
                <div class="stat-card p-5">
                    <p class="text-3xl md:text-4xl font-bold text-white">30-80%</p>
                    <p class="text-text-secondary text-sm mt-1">PONV incidence without prophylaxis in high-risk patients</p>
                </div>
                <div class="stat-card p-5">
                    <p class="text-3xl md:text-4xl font-bold text-white">~26%</p>
                    <p class="text-text-secondary text-sm mt-1">Relative risk reduction per antiemetic intervention</p>
                </div>
                <div class="stat-card p-5">
                    <p class="text-3xl md:text-4xl font-bold text-white">$0.50-$150</p>
                    <p class="text-text-secondary text-sm mt-1">Wide range in antiemetic costs‚Äîdexamethasone to aprepitant</p>
                </div>
            </div>

            <p class="text-text-secondary text-sm mb-3">As the anesthesiologist, you control key modifiable factors:</p>
            <div class="flex flex-wrap gap-2">
                <span class="badge-dark badge">Risk stratification (Apfel score)</span>
                <span class="badge-dark badge">Antiemetic selection</span>
                <span class="badge-dark badge">TIVA vs volatile</span>
                <span class="badge-dark badge">Opioid-sparing techniques</span>
                <span class="badge-dark badge">Cost-effectiveness</span>
            </div>
        </section>

        <!-- Side-by-Side Study Cards -->
        <section class="grid md:grid-cols-2 gap-6">
            <!-- Apfel Card -->
            <div class="study-card">
                <div class="p-5">
                    <div class="flex items-center justify-between mb-3">
                        <span class="text-accent-teal text-xs font-semibold tracking-wider">NEJM 2004</span>
                        <span class="badge badge-green">Positive</span>
                    </div>
                    <h3 class="text-xl font-bold text-white mb-2">Apfel et al.</h3>
                    <p class="text-text-secondary text-sm">
                        <strong class="text-white">Factorial trial:</strong> Six interventions tested in >5,000 patients to determine individual and combined <span class="text-accent-teal">additive</span> effects.
                    </p>

                    <div class="outcome-box mt-4">
                        <p class="text-text-muted text-xs uppercase tracking-wider mb-3">Primary Finding: Additive Effects</p>
                        <div class="flex items-center justify-center gap-3">
                            <span class="text-3xl font-bold text-accent-teal">1+1</span>
                            <span class="text-text-muted">=</span>
                            <span class="text-3xl font-bold text-accent-teal">2</span>
                        </div>
                        <p class="text-center text-text-muted text-xs mt-2">~26% RRR per antiemetic</p>
                    </div>

                    <div class="flex flex-wrap gap-2 mt-4">
                        <span class="badge-dark badge">n = 5,161</span>
                        <span class="badge-dark badge">64 combinations</span>
                        <span class="badge-dark badge">Multicenter</span>
                    </div>
                </div>
            </div>

            <!-- Grigio Card -->
            <div class="study-card">
                <div class="p-5">
                    <div class="flex items-center justify-between mb-3">
                        <span class="text-accent-gold text-xs font-semibold tracking-wider">BRAZ J ANESTH 2020</span>
                        <span class="badge badge-gray">Null</span>
                    </div>
                    <h3 class="text-xl font-bold text-white mb-2">Grigio et al.</h3>
                    <p class="text-text-secondary text-sm">
                        <strong class="text-white">Small RCT:</strong> Aprepitant added to <span class="text-accent-gold">palonosetron + dexamethasone</span> in high-risk mastectomy patients.
                    </p>

                    <div class="outcome-box mt-4">
                        <p class="text-text-muted text-xs uppercase tracking-wider mb-3">Primary Outcome: PONV</p>
                        <div class="flex items-center justify-center gap-4">
                            <div class="text-center">
                                <span class="text-2xl font-bold text-text-secondary">Aprepitant</span>
                            </div>
                            <span class="text-text-muted">vs</span>
                            <div class="text-center">
                                <span class="text-2xl font-bold text-text-secondary">Placebo</span>
                            </div>
                        </div>
                        <p class="text-center text-text-muted text-sm mt-2">p = NS &nbsp;Not significant</p>
                    </div>

                    <div class="flex flex-wrap gap-2 mt-4">
                        <span class="badge-dark badge">n = 91</span>
                        <span class="badge-dark badge">Apfel 3-4</span>
                        <span class="badge-dark badge">Single-center</span>
                    </div>
                </div>
            </div>
        </section>

        <!-- Comparison Table -->
        <section class="card p-6 overflow-x-auto">
            <h2 class="text-lg font-bold text-white mb-4">Achieved Separation in Antiemetic Exposure</h2>
            <table class="w-full text-sm">
                <thead>
                <tr class="border-b border-dark-border">
                    <th class="text-left py-3 px-2 font-medium text-text-secondary">Metric</th>
                    <th class="text-center py-3 px-2 font-medium text-accent-teal">Apfel et al.</th>
                    <th class="text-center py-3 px-2 font-medium text-text-secondary">Grigio et al.</th>
                </tr>
                </thead>
                <tbody class="divide-y divide-dark-border">
                <tr>
                    <td class="py-3 px-2 text-text-secondary">Sample Size</td>
                    <td class="py-3 px-2 text-center text-white font-medium">5,161</td>
                    <td class="py-3 px-2 text-center text-white font-medium">91</td>
                </tr>
                <tr>
                    <td class="py-3 px-2 text-text-secondary">Design</td>
                    <td class="py-3 px-2 text-center text-text-primary">6-factor factorial RCT</td>
                    <td class="py-3 px-2 text-center text-text-primary">Double-blind RCT</td>
                </tr>
                <tr>
                    <td class="py-3 px-2 text-text-secondary">Antiemetics Tested</td>
                    <td class="py-3 px-2 text-center text-text-primary">Ondansetron, dexamethasone, droperidol</td>
                    <td class="py-3 px-2 text-center text-text-primary">Palonosetron, dexamethasone, aprepitant</td>
                </tr>
                <tr>
                    <td class="py-3 px-2 text-text-secondary">Key Finding</td>
                    <td class="py-3 px-2 text-center text-accent-teal font-medium">Additive effect ~26% RRR per agent</td>
                    <td class="py-3 px-2 text-center text-text-muted">No difference with aprepitant</td>
                </tr>
                <tr>
                    <td class="py-3 px-2 text-text-secondary">Main Limitation</td>
                    <td class="py-3 px-2 text-center text-text-primary">Clinicians not blinded intra-op</td>
                    <td class="py-3 px-2 text-center text-accent-gold font-medium">Severely underpowered</td>
                </tr>
                </tbody>
            </table>
        </section>

        <!-- Reconciling Results -->
        <section class="card p-6">
            <h2 class="text-lg font-bold text-white mb-2">Reconciling the Results: Why Do These Trials Differ?</h2>
            <p class="text-text-muted text-sm mb-6">Four key factors explain the divergent findings</p>

            <div class="grid md:grid-cols-2 gap-4">
                <div class="card-alt p-4">
                    <div class="flex items-start gap-3">
                        <div class="number-badge bg-accent-teal/20 text-accent-teal">1</div>
                        <div>
                            <h3 class="font-semibold text-white mb-1">Different Generations of Antiemetics</h3>
                            <p class="text-text-secondary text-sm">Apfel studied first-generation 5-HT3 antagonists. Palonosetron has different pharmacokinetics that may not follow the same additive model.</p>
                        </div>
                    </div>
                </div>
                <div class="card-alt p-4">
                    <div class="flex items-start gap-3">
                        <div class="number-badge bg-accent-teal/20 text-accent-teal">2</div>
                        <div>
                            <h3 class="font-semibold text-white mb-1">Power to Detect Differences</h3>
                            <p class="text-text-secondary text-sm">Grigio's 91 patients vs Apfel's 5,161. The smaller study cannot detect the ~26% RRR each agent provides.</p>
                        </div>
                    </div>
                </div>
                <div class="card-alt p-4">
                    <div class="flex items-start gap-3">
                        <div class="number-badge bg-accent-teal/20 text-accent-teal">3</div>
                        <div>
                            <h3 class="font-semibold text-white mb-1">Confounding: Dexamethasone Dosing</h3>
                            <p class="text-text-secondary text-sm">Grigio used 8mg dexamethasone in aprepitant group vs 4mg in placebo‚Äîconfounding interpretation.</p>
                        </div>
                    </div>
                </div>
                <div class="card-alt p-4">
                    <div class="flex items-start gap-3">
                        <div class="number-badge bg-accent-teal/20 text-accent-teal">4</div>
                        <div>
                            <h3 class="font-semibold text-white mb-1">Ceiling Effect Consideration</h3>
                            <p class="text-text-secondary text-sm">When baseline prophylaxis is robust, incremental benefit from additional agents becomes harder to demonstrate.</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- Cost-Effectiveness -->
        <section class="card p-6">
            <h2 class="text-lg font-bold text-white mb-4">Cost-Effectiveness: Practical Tiering</h2>

            <div class="space-y-3">
                <div class="card-alt p-4 flex items-center gap-4 border-l-4 border-accent-green">
                    <div class="w-14 h-14 bg-accent-green/20 rounded-xl flex items-center justify-center text-accent-green text-xl font-bold flex-shrink-0">$</div>
                    <div class="flex-1">
                        <h3 class="font-semibold text-white">First Line: Ondansetron + Dexamethasone</h3>
                        <p class="text-text-secondary text-sm">Almost always cost-effective regardless of baseline risk. Combined cost &lt;$2.</p>
                    </div>
                    <span class="badge badge-green hidden md:inline-flex">Recommended</span>
                </div>

                <div class="card-alt p-4 flex items-center gap-4 border-l-4 border-accent-teal">
                    <div class="w-14 h-14 bg-accent-teal/20 rounded-xl flex items-center justify-center text-accent-teal text-xl font-bold flex-shrink-0">$$</div>
                    <div class="flex-1">
                        <h3 class="font-semibold text-white">Second Line: Low-dose Droperidol or Haloperidol</h3>
                        <p class="text-text-secondary text-sm">Inexpensive third-line option. CA-3s expressed limited familiarity.</p>
                    </div>
                    <span class="badge badge-teal hidden md:inline-flex">Underutilized</span>
                </div>

                <div class="card-alt p-4 flex items-center gap-4 border-l-4 border-accent-gold">
                    <div class="w-14 h-14 bg-accent-gold/20 rounded-xl flex items-center justify-center text-accent-gold text-xl font-bold flex-shrink-0">$$$</div>
                    <div class="flex-1">
                        <h3 class="font-semibold text-white">Third Line: Palonosetron, Aprepitant</h3>
                        <p class="text-text-secondary text-sm">Supported for delayed PONV. Uncertain additive benefit when multiple agents already used.</p>
                    </div>
                    <span class="badge badge-gold hidden md:inline-flex">Selective Use</span>
                </div>
            </div>
        </section>

        <!-- Bottom Line -->
        <section class="card p-6 bg-gradient-to-r from-dark-card to-dark-card-alt">
            <h2 class="text-lg font-bold text-accent-gold mb-4 flex items-center gap-2">
                üéØ The Bottom Line
            </h2>
            <div class="grid md:grid-cols-2 gap-3">
                <div class="card-alt p-4 flex items-start gap-3">
                    <span class="text-accent-teal">‚ñ∏</span>
                    <p class="text-text-primary text-sm">Antiemetic effects are <strong class="text-white">additive (~26% RRR each)</strong>, not synergistic‚Äîuse baseline risk to guide prophylaxis intensity.</p>
                </div>
                <div class="card-alt p-4 flex items-start gap-3">
                    <span class="text-accent-teal">‚ñ∏</span>
                    <p class="text-text-primary text-sm"><strong class="text-white">Ondansetron + dexamethasone</strong> is cost-effective for nearly all patients.</p>
                </div>
                <div class="card-alt p-4 flex items-start gap-3">
                    <span class="text-accent-teal">‚ñ∏</span>
                    <p class="text-text-primary text-sm"><strong class="text-white">Droperidol/haloperidol</strong> is an underutilized, inexpensive third-line option.</p>
                </div>
                <div class="card-alt p-4 flex items-start gap-3">
                    <span class="text-accent-teal">‚ñ∏</span>
                    <p class="text-text-primary text-sm"><strong class="text-white">Newer agents</strong> may have diminishing returns when added to robust multimodal prophylaxis.</p>
                </div>
            </div>
        </section>
    </div>

    <!-- Apfel Tab -->
    <div id="apfel" class="tab-content space-y-6">
        <div class="flex items-center gap-3 mb-2">
            <span class="badge badge-teal">üìä</span>
            <span class="text-text-secondary text-sm">NEJM 2004</span>
        </div>

        <h2 class="text-2xl md:text-3xl font-bold text-white mb-6">Apfel et al. ‚Äî Deep Dive</h2>

        <!-- PICO -->
        <div class="grid md:grid-cols-2 gap-4">
            <div class="card p-5">
                <div class="flex items-center gap-3 mb-3">
                    <div class="pico-badge bg-blue-500/20 text-blue-400">P</div>
                    <h3 class="font-semibold text-white">Population</h3>
                </div>
                <ul class="text-sm text-text-secondary space-y-1 ml-10">
                    <li>‚Ä¢ Adults undergoing surgery with GA</li>
                    <li>‚Ä¢ 5,161 patients across multiple centers</li>
                    <li>‚Ä¢ Varied PONV risk profiles</li>
                    <li>‚Ä¢ Expected hospital stay ‚â•24 hours</li>
                </ul>
            </div>

            <div class="card p-5">
                <div class="flex items-center gap-3 mb-3">
                    <div class="pico-badge bg-emerald-500/20 text-emerald-400">I</div>
                    <h3 class="font-semibold text-white">Interventions</h3>
                </div>
                <ul class="text-sm text-text-secondary space-y-1 ml-10">
                    <li>‚Ä¢ Ondansetron 4mg vs none</li>
                    <li>‚Ä¢ Dexamethasone 4mg vs none</li>
                    <li>‚Ä¢ Droperidol 1.25mg vs none</li>
                    <li>‚Ä¢ Propofol vs volatile</li>
                    <li>‚Ä¢ N‚ÇÇ vs N‚ÇÇO</li>
                    <li>‚Ä¢ Remifentanil vs fentanyl</li>
                </ul>
            </div>

            <div class="card p-5">
                <div class="flex items-center gap-3 mb-3">
                    <div class="pico-badge bg-amber-500/20 text-amber-400">C</div>
                    <h3 class="font-semibold text-white">Comparator</h3>
                </div>
                <p class="text-sm text-text-secondary ml-10">
                    Factorial design: Each intervention compared against its absence. 64 possible combinations allowed assessment of individual and combined effects.
                </p>
            </div>

            <div class="card p-5">
                <div class="flex items-center gap-3 mb-3">
                    <div class="pico-badge bg-purple-500/20 text-purple-400">O</div>
                    <h3 class="font-semibold text-white">Outcomes</h3>
                </div>
                <ul class="text-sm text-text-secondary space-y-1 ml-10">
                    <li>‚Ä¢ <strong class="text-white">Primary:</strong> PONV within 24 hours</li>
                    <li>‚Ä¢ Nausea (VAS ‚â•1)</li>
                    <li>‚Ä¢ Vomiting episodes</li>
                    <li>‚Ä¢ Rescue antiemetic use</li>
                </ul>
            </div>
        </div>

        <!-- Key Results -->
        <div class="card p-6">
            <h3 class="text-lg font-bold text-white mb-4">Key Results</h3>
            <div class="grid md:grid-cols-3 gap-4 mb-4">
                <div class="stat-card p-4 text-center">
                    <p class="text-3xl font-bold text-accent-teal">~26%</p>
                    <p class="text-sm text-text-secondary">RRR per antiemetic</p>
                </div>
                <div class="stat-card p-4 text-center">
                    <p class="text-3xl font-bold text-accent-teal">Additive</p>
                    <p class="text-sm text-text-secondary">Effects combine predictably</p>
                </div>
                <div class="stat-card p-4 text-center">
                    <p class="text-3xl font-bold text-accent-gold">~19%</p>
                    <p class="text-sm text-text-secondary">RRR with propofol vs volatile</p>
                </div>
            </div>
            <div class="card-alt p-4">
                <p class="text-text-secondary text-sm">
                    <strong class="text-white">Clinical implication:</strong> Baseline PONV risk should guide the number of prophylactic interventions. Each additional agent provides consistent, predictable benefit.
                </p>
            </div>
        </div>

        <!-- Strengths & Limitations -->
        <div class="grid md:grid-cols-2 gap-4">
            <div class="card p-5 border-l-4 border-accent-green">
                <h3 class="font-semibold text-accent-green mb-3 flex items-center gap-2">
                    <svg class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"></path></svg>
                    Strengths
                </h3>
                <ul class="text-sm text-text-secondary space-y-2">
                    <li>‚Ä¢ Large, well-powered sample (n=5,161)</li>
                    <li>‚Ä¢ Factorial design enables individual effect assessment</li>
                    <li>‚Ä¢ Multicenter‚Äîimproves generalizability</li>
                    <li>‚Ä¢ Outcome assessors blinded</li>
                    <li>‚Ä¢ Clear, reproducible findings</li>
                </ul>
            </div>

            <div class="card p-5 border-l-4 border-accent-red">
                <h3 class="font-semibold text-accent-red mb-3 flex items-center gap-2">
                    <svg class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"></path></svg>
                    Limitations
                </h3>
                <ul class="text-sm text-text-secondary space-y-2">
                    <li>‚Ä¢ Intra-operative clinicians not blinded</li>
                    <li>‚Ä¢ Does not include newer antiemetics</li>
                    <li>‚Ä¢ 24-hour outcome‚Äîdoesn't capture delayed PONV</li>
                    <li>‚Ä¢ Published 2004‚Äîsome practices evolved</li>
                </ul>
            </div>
        </div>

        <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa032196" target="_blank"
           class="inline-flex items-center gap-2 text-accent-teal hover:text-accent-gold font-medium no-print transition-colors">
            <svg class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M10 6H6a2 2 0 00-2 2v10a2 2 0 002 2h10a2 2 0 002-2v-4M14 4h6m0 0v6m0-6L10 14"></path>
            </svg>
            Read Full Article (NEJM)
        </a>
    </div>

    <!-- Grigio Tab -->
    <div id="grigio" class="tab-content space-y-6">
        <div class="flex items-center gap-3 mb-2">
            <span class="badge badge-gold">üìä</span>
            <span class="text-text-secondary text-sm">Brazilian J Anesthesiol 2020</span>
        </div>

        <h2 class="text-2xl md:text-3xl font-bold text-white mb-6">Grigio et al. ‚Äî Deep Dive</h2>

        <!-- PICO -->
        <div class="grid md:grid-cols-2 gap-4">
            <div class="card p-5">
                <div class="flex items-center gap-3 mb-3">
                    <div class="pico-badge bg-blue-500/20 text-blue-400">P</div>
                    <h3 class="font-semibold text-white">Population</h3>
                </div>
                <ul class="text-sm text-text-secondary space-y-1 ml-10">
                    <li>‚Ä¢ Adults undergoing unilateral mastectomy</li>
                    <li>‚Ä¢ High PONV risk: Apfel score 3-4</li>
                    <li>‚Ä¢ 91 patients total</li>
                    <li>‚Ä¢ All received propofol/remifentanil TIVA</li>
                </ul>
            </div>

            <div class="card p-5">
                <div class="flex items-center gap-3 mb-3">
                    <div class="pico-badge bg-emerald-500/20 text-emerald-400">I</div>
                    <h3 class="font-semibold text-white">Intervention</h3>
                </div>
                <ul class="text-sm text-text-secondary space-y-1 ml-10">
                    <li>‚Ä¢ Oral aprepitant 80mg</li>
                    <li>‚Ä¢ IV dexamethasone <strong class="text-accent-gold">8mg</strong></li>
                    <li>‚Ä¢ IV palonosetron 0.075mg</li>
                </ul>
            </div>

            <div class="card p-5">
                <div class="flex items-center gap-3 mb-3">
                    <div class="pico-badge bg-amber-500/20 text-amber-400">C</div>
                    <h3 class="font-semibold text-white">Comparator</h3>
                </div>
                <ul class="text-sm text-text-secondary space-y-1 ml-10">
                    <li>‚Ä¢ Oral placebo</li>
                    <li>‚Ä¢ IV dexamethasone <strong class="text-white">4mg</strong></li>
                    <li>‚Ä¢ IV palonosetron 0.075mg</li>
                </ul>
                <p class="text-xs text-accent-gold mt-2 ml-10 font-medium">‚ö†Ô∏è Note: Different dexamethasone doses between groups</p>
            </div>

            <div class="card p-5">
                <div class="flex items-center gap-3 mb-3">
                    <div class="pico-badge bg-purple-500/20 text-purple-400">O</div>
                    <h3 class="font-semibold text-white">Outcomes</h3>
                </div>
                <ul class="text-sm text-text-secondary space-y-1 ml-10">
                    <li>‚Ä¢ PONV at multiple timepoints</li>
                    <li>‚Ä¢ Rescue antiemetic use</li>
                    <li>‚Ä¢ Complete response (no PONV, no rescue)</li>
                </ul>
            </div>
        </div>

        <!-- The Null Result -->
        <div class="card p-6">
            <h3 class="text-lg font-bold text-white mb-4">The Null Result</h3>
            <div class="outcome-box text-center">
                <p class="text-2xl font-bold text-text-muted">No significant difference</p>
                <p class="text-text-muted text-sm mt-2">Despite adding aprepitant (and higher-dose dexamethasone), no statistically significant reduction in PONV at any timepoint.</p>
            </div>
        </div>

        <!-- Discussion Points -->
        <div class="card p-6">
            <h3 class="text-lg font-bold text-white mb-4">Journal Club Discussion Points</h3>
            <div class="space-y-3">
                <div class="card-alt p-4 border-l-4 border-accent-gold">
                    <div class="flex items-start gap-3">
                        <span class="number-badge bg-accent-gold/20 text-accent-gold">1</span>
                        <div>
                            <p class="font-semibold text-white">Severely Underpowered</p>
                            <p class="text-sm text-text-secondary">With only 91 patients, the study lacks power to detect the ~26% RRR that each antiemetic provides.</p>
                        </div>
                    </div>
                </div>
                <div class="card-alt p-4 border-l-4 border-amber-500">
                    <div class="flex items-start gap-3">
                        <span class="number-badge bg-amber-500/20 text-amber-400">2</span>
                        <div>
                            <p class="font-semibold text-white">Confounding: Differential Dexamethasone</p>
                            <p class="text-sm text-text-secondary">8mg vs 4mg dexamethasone between groups confounds interpretation of aprepitant's contribution.</p>
                        </div>
                    </div>
                </div>
                <div class="card-alt p-4 border-l-4 border-accent-teal">
                    <div class="flex items-start gap-3">
                        <span class="number-badge bg-accent-teal/20 text-accent-teal">3</span>
                        <div>
                            <p class="font-semibold text-white">Ceiling Effect Hypothesis</p>
                            <p class="text-sm text-text-secondary">When baseline prophylaxis is already robust, incremental benefit becomes harder to demonstrate.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Strengths & Limitations -->
        <div class="grid md:grid-cols-2 gap-4">
            <div class="card p-5 border-l-4 border-accent-green">
                <h3 class="font-semibold text-accent-green mb-3 flex items-center gap-2">
                    <svg class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M5 13l4 4L19 7"></path></svg>
                    Strengths
                </h3>
                <ul class="text-sm text-text-secondary space-y-2">
                    <li>‚Ä¢ Double-blinded RCT</li>
                    <li>‚Ä¢ High-risk population (Apfel 3-4)</li>
                    <li>‚Ä¢ Standardized TIVA protocol</li>
                    <li>‚Ä¢ Multiple assessment timepoints</li>
                </ul>
            </div>

            <div class="card p-5 border-l-4 border-accent-red">
                <h3 class="font-semibold text-accent-red mb-3 flex items-center gap-2">
                    <svg class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z"></path></svg>
                    Limitations
                </h3>
                <ul class="text-sm text-text-secondary space-y-2">
                    <li>‚Ä¢ <strong class="text-white">Severely underpowered</strong> (n=91)</li>
                    <li>‚Ä¢ Differential dexamethasone dosing</li>
                    <li>‚Ä¢ Single surgical population</li>
                    <li>‚Ä¢ Cannot draw definitive conclusions</li>
                </ul>
            </div>
        </div>

        <a href="https://www.sciencedirect.com/science/article/pii/S1807593222004690" target="_blank"
           class="inline-flex items-center gap-2 text-accent-teal hover:text-accent-gold font-medium no-print transition-colors">
            <svg class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M10 6H6a2 2 0 00-2 2v10a2 2 0 002 2h10a2 2 0 002-2v-4M14 4h6m0 0v6m0-6L10 14"></path>
            </svg>
            Read Full Article (ScienceDirect)
        </a>
    </div>

    <!-- Discussion Insights Tab -->
    <div id="discussion" class="tab-content space-y-6">
        <div class="flex items-center gap-3 mb-2">
            <span class="badge badge-gold">üí¨</span>
            <span class="text-text-secondary text-sm">Key Takeaways from Group Discussion</span>
        </div>

        <h2 class="text-2xl md:text-3xl font-bold text-white mb-2">Discussion Insights</h2>
        <p class="text-text-muted mb-6">Highlights and clinical pearls that emerged during our journal club conversation</p>

        <!-- The Aha Moment -->
        <section class="card p-6">
            <h3 class="text-lg font-bold text-accent-gold mb-4 flex items-center gap-2">
                <span>‚ö°</span> The "Aha" Moment
            </h3>
            <div class="card-alt p-5">
                <p class="text-white text-lg leading-relaxed">
                    "If antiemetic effects are truly <em class="text-accent-teal">additive</em> and not synergistic, then the <strong>marginal benefit of each additional agent is predictable</strong>‚Äîbut the <strong>marginal cost</strong> varies wildly. This reframes PONV prophylaxis as an optimization problem, not just 'more is better.'"
                </p>
            </div>
        </section>

        <!-- Clinical Pearls -->
        <section class="card p-6">
            <h3 class="text-lg font-bold text-white mb-4 flex items-center gap-2">
                <span>üíé</span> Clinical Pearls from the Room
            </h3>

            <div class="space-y-3">
                <div class="card-alt p-4 border-l-4 border-accent-green">
                    <div class="flex gap-3">
                        <span class="number-badge bg-accent-green/20 text-accent-green flex-shrink-0">1</span>
                        <div>
                            <h4 class="font-semibold text-white">Start with the Apfel Score‚ÄîBut Don't Stop There</h4>
                            <p class="text-text-secondary text-sm mt-1">Consider surgery type, history of motion sickness, and patient expectations. A patient who "always gets sick" deserves aggressive prophylaxis regardless of calculated score.</p>
                        </div>
                    </div>
                </div>

                <div class="card-alt p-4 border-l-4 border-accent-teal">
                    <div class="flex gap-3">
                        <span class="number-badge bg-accent-teal/20 text-accent-teal flex-shrink-0">2</span>
                        <div>
                            <h4 class="font-semibold text-white">The "Why Not Both?" Trap</h4>
                            <p class="text-text-secondary text-sm mt-1">If you've already given ondansetron + dexamethasone + scopolamine + TIVA, the fifth agent is fighting diminishing returns. Save expensive options for rescue or delayed PONV.</p>
                        </div>
                    </div>
                </div>

                <div class="card-alt p-4 border-l-4 border-accent-gold">
                    <div class="flex gap-3">
                        <span class="number-badge bg-accent-gold/20 text-accent-gold flex-shrink-0">3</span>
                        <div>
                            <h4 class="font-semibold text-white">Droperidol Deserves a Second Look</h4>
                            <p class="text-text-secondary text-sm mt-1">At antiemetic doses (0.625-1.25mg), the QTc risk is minimal. Multiple residents admitted they'd never used it‚Äîit's effective, cheap, and underutilized.</p>
                        </div>
                    </div>
                </div>

                <div class="card-alt p-4 border-l-4 border-purple-500">
                    <div class="flex gap-3">
                        <span class="number-badge bg-purple-500/20 text-purple-400 flex-shrink-0">4</span>
                        <div>
                            <h4 class="font-semibold text-white">Timing Matters More Than We Think</h4>
                            <p class="text-text-secondary text-sm mt-1">Palonosetron's 40-hour half-life means it's particularly useful for delayed PONV. Match the drug's pharmacokinetics to the expected PONV timeline.</p>
                        </div>
                    </div>
                </div>

                <div class="card-alt p-4 border-l-4 border-pink-500">
                    <div class="flex gap-3">
                        <span class="number-badge bg-pink-500/20 text-pink-400 flex-shrink-0">5</span>
                        <div>
                            <h4 class="font-semibold text-white">Don't Forget the Non-Pharmacologic</h4>
                            <p class="text-text-secondary text-sm mt-1">Adequate hydration, minimizing opioids, avoiding gastric insufflation, and even acupressure at P6 all contribute. These "free" interventions should be standard.</p>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <!-- Attending Perspective -->
        <section class="card p-6">
            <h3 class="text-lg font-bold text-accent-teal mb-4 flex items-center gap-2">
                <span>üéì</span> Attending Perspective
            </h3>
            <div class="grid md:grid-cols-2 gap-4">
                <div class="card-alt p-4">
                    <p class="text-accent-teal text-sm font-medium mb-2">Dr. Ibekwe</p>
                    <p class="text-text-secondary text-sm italic">"The Grigio paper is a good example of why we need to read past the abstract. A null result from an underpowered study tells us nothing‚Äîit doesn't mean aprepitant doesn't work, it means we still don't know."</p>
                </div>
                <div class="card-alt p-4">
                    <p class="text-accent-gold text-sm font-medium mb-2">Dr. White</p>
                    <p class="text-text-secondary text-sm italic">"I'd encourage everyone to get comfortable with droperidol. At low doses, it's one of the most cost-effective tools we have. The black box warning created a generation of anesthesiologists who never learned to use it."</p>
                </div>
            </div>
        </section>

        <!-- Questions That Sparked Discussion -->
        <section class="card p-6">
            <h3 class="text-lg font-bold text-white mb-4 flex items-center gap-2">
                <span>‚ùì</span> Questions That Sparked Discussion
            </h3>

            <div class="space-y-4">
                <div class="border-b border-dark-border pb-4">
                    <p class="font-medium text-white mb-2">"If I've given three antiemetics and the patient still vomits in PACU, should I reach for a fourth class or repeat one that worked before?"</p>
                    <p class="text-text-secondary text-sm"><strong class="text-accent-teal">Consensus:</strong> Try a different mechanism first. If they've had ondansetron, dexamethasone, and scopolamine, consider promethazine or low-dose haloperidol.</p>
                </div>

                <div class="border-b border-dark-border pb-4">
                    <p class="font-medium text-white mb-2">"Does TIVA really make that much difference?"</p>
                    <p class="text-text-secondary text-sm"><strong class="text-accent-teal">Consensus:</strong> The ~19% RRR from propofol TIVA vs volatile is real and meaningful in high-risk patients. Worth it for Apfel 3-4 patients, especially ambulatory surgery.</p>
                </div>

                <div class="border-b border-dark-border pb-4">
                    <p class="font-medium text-white mb-2">"When is aprepitant actually worth the cost?"</p>
                    <p class="text-text-secondary text-sm"><strong class="text-accent-teal">Consensus:</strong> Consider for highly emetogenic chemotherapy and patients with severe PONV history despite aggressive prophylaxis. Not routine first-line given cost.</p>
                </div>

                <div>
                    <p class="font-medium text-white mb-2">"Should we be documenting Apfel scores in our preop assessment?"</p>
                    <p class="text-text-secondary text-sm"><strong class="text-accent-teal">Consensus:</strong> Yes‚Äîit takes 10 seconds and creates a rational framework. Helps with handoffs and some institutions have built it into EMR templates.</p>
                </div>
            </div>
        </section>

        <!-- Practice Changes -->
        <section class="card p-6 bg-gradient-to-r from-dark-card to-dark-card-alt">
            <h3 class="text-lg font-bold text-accent-gold mb-4 flex items-center gap-2">
                <span>üîÑ</span> Proposed Practice Changes
            </h3>
            <p class="text-text-secondary mb-4">Based on our discussion, actionable changes residents committed to trying:</p>

            <div class="grid md:grid-cols-2 gap-3">
                <div class="card-alt p-4">
                    <div class="flex items-center gap-2 mb-2">
                        <span class="w-5 h-5 bg-accent-green rounded-full flex items-center justify-center text-white text-xs">‚úì</span>
                        <span class="text-white font-medium">Document Apfel Score</span>
                    </div>
                    <p class="text-text-secondary text-sm">Add Apfel score calculation to preop assessment workflow</p>
                </div>

                <div class="card-alt p-4">
                    <div class="flex items-center gap-2 mb-2">
                        <span class="w-5 h-5 bg-accent-green rounded-full flex items-center justify-center text-white text-xs">‚úì</span>
                        <span class="text-white font-medium">Trial Droperidol</span>
                    </div>
                    <p class="text-text-secondary text-sm">Use low-dose droperidol (0.625mg) as third-line in next 5 high-risk cases</p>
                </div>

                <div class="card-alt p-4">
                    <div class="flex items-center gap-2 mb-2">
                        <span class="w-5 h-5 bg-accent-green rounded-full flex items-center justify-center text-white text-xs">‚úì</span>
                        <span class="text-white font-medium">Reserve Expensive Agents</span>
                    </div>
                    <p class="text-text-secondary text-sm">Use palonosetron/aprepitant for rescue or delayed PONV, not routine</p>
                </div>

                <div class="card-alt p-4">
                    <div class="flex items-center gap-2 mb-2">
                        <span class="w-5 h-5 bg-accent-green rounded-full flex items-center justify-center text-white text-xs">‚úì</span>
                        <span class="text-white font-medium">TIVA for Apfel 4</span>
                    </div>
                    <p class="text-text-secondary text-sm">Default to propofol TIVA for Apfel score 4 patients when feasible</p>
                </div>
            </div>
        </section>

        <!-- Unresolved Questions -->
        <section class="card p-6">
            <h3 class="text-lg font-bold text-white mb-4 flex items-center gap-2">
                <span>ü§î</span> Unresolved Questions for Future Reading
            </h3>
            <ul class="space-y-3 text-text-secondary">
                <li class="flex items-start gap-3">
                    <span class="text-accent-teal">‚Üí</span>
                    <span>Does palonosetron's longer half-life translate to clinically meaningful superiority for 24-48 hour PONV prevention?</span>
                </li>
                <li class="flex items-start gap-3">
                    <span class="text-accent-teal">‚Üí</span>
                    <span>What's the actual ceiling effect threshold‚Äîis there a point where additional antiemetics provide zero benefit?</span>
                </li>
                <li class="flex items-start gap-3">
                    <span class="text-accent-teal">‚Üí</span>
                    <span>Are there genetic polymorphisms (5-HT3 receptor variants) that predict antiemetic response?</span>
                </li>
                <li class="flex items-start gap-3">
                    <span class="text-accent-teal">‚Üí</span>
                    <span>How should we approach the "always gets sick" patient‚Äîis there a role for preoperative conditioning or anxiolytics?</span>
                </li>
            </ul>
        </section>
    </div>

    <!-- Quiz Tab -->
    <div id="quiz" class="tab-content space-y-6">
        <div class="card p-6">
            <div class="flex items-center justify-between mb-6">
                <h2 class="text-xl font-bold text-white">Knowledge Check</h2>
                <div class="flex items-center gap-4">
                    <p class="text-text-secondary">Score: <span id="score" class="font-bold text-accent-teal">0</span> / 10</p>
                    <button onclick="resetQuiz()" class="px-4 py-2 bg-dark-card-alt hover:bg-dark-border rounded-lg text-sm font-medium transition-colors text-text-secondary no-print">
                        Reset
                    </button>
                </div>
            </div>
            <p class="text-text-muted mb-6">Test your understanding of both studies</p>

            <div id="quiz-container" class="space-y-6">
                <!-- Question 1 -->
                <div class="quiz-question card-alt p-5" data-correct="B" data-points="1">
                    <h3 class="font-medium text-white mb-4">1. According to Apfel et al., the effects of multiple antiemetics on PONV prevention are:</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> Synergistic (1 + 1 = 3)
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> Additive (1 + 1 = 2)
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> Antagonistic (1 + 1 = 0.5)
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> Variable depending on patient risk
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 2 -->
                <div class="quiz-question card-alt p-5" data-correct="C" data-points="1">
                    <h3 class="font-medium text-white mb-4">2. What approximate relative risk reduction does each antiemetic provide according to Apfel's findings?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> ~10%
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> ~15%
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> ~26%
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> ~50%
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 3 -->
                <div class="quiz-question card-alt p-5" data-correct="D" data-points="1">
                    <h3 class="font-medium text-white mb-4">3. Which antiemetic was NOT studied in the Apfel et al. factorial trial?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> Ondansetron
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> Dexamethasone
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> Droperidol
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> Palonosetron
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 4 -->
                <div class="quiz-question card-alt p-5" data-correct="A" data-points="1">
                    <h3 class="font-medium text-white mb-4">4. What was the primary limitation identified in the Grigio et al. study?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> Severely underpowered (only 91 patients)
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> Patients were not blinded
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> Follow-up was only 6 hours
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> Only low-risk patients were included
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 5 -->
                <div class="quiz-question card-alt p-5" data-correct="B" data-points="1">
                    <h3 class="font-medium text-white mb-4">5. What confounding variable existed between groups in the Grigio study?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> Different surgical procedures
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> Different dexamethasone doses (8mg vs 4mg)
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> Different anesthetic techniques
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> Different Apfel scores between groups
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 6 -->
                <div class="quiz-question card-alt p-5" data-correct="C" data-points="1">
                    <h3 class="font-medium text-white mb-4">6. Which combination is almost always cost-effective regardless of baseline PONV risk?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> Palonosetron + aprepitant
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> Droperidol + haloperidol
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> Ondansetron + dexamethasone
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> Aprepitant alone
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 7 -->
                <div class="quiz-question card-alt p-5" data-correct="D" data-points="1">
                    <h3 class="font-medium text-white mb-4">7. Which medication class did CA-3 residents express apprehension about using?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> 5-HT3 antagonists
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> Corticosteroids
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> NK-1 antagonists
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> Butyrophenones (droperidol/haloperidol)
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 8 -->
                <div class="quiz-question card-alt p-5" data-correct="A" data-points="1">
                    <h3 class="font-medium text-white mb-4">8. How many treatment variables were included in the Apfel et al. factorial design?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> 6
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> 4
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> 8
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> 3
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 9 -->
                <div class="quiz-question card-alt p-5" data-correct="B" data-points="1">
                    <h3 class="font-medium text-white mb-4">9. What was the notable limitation of Apfel et al. regarding blinding?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> Outcome assessors were not blinded
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> Intra-operative anesthesia clinicians were not blinded
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> Patients were aware of their treatment
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> No blinding was performed
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>

                <!-- Question 10 -->
                <div class="quiz-question card-alt p-5" data-correct="C" data-points="1">
                    <h3 class="font-medium text-white mb-4">10. When should you be most cautious about expecting benefit from newer antiemetics like aprepitant?</h3>
                    <div class="space-y-2">
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="A">
                            <span class="font-medium text-text-muted">A.</span> In patients with low baseline risk
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="B">
                            <span class="font-medium text-text-muted">B.</span> When no other prophylaxis is planned
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="C">
                            <span class="font-medium text-text-muted">C.</span> When multiple other antiemetics have already been implemented
                        </button>
                        <button class="quiz-option w-full text-left p-3 rounded-lg text-text-primary" data-option="D">
                            <span class="font-medium text-text-muted">D.</span> During short ambulatory procedures
                        </button>
                    </div>
                    <div class="feedback hidden mt-4 p-3 rounded-lg text-sm"></div>
                </div>
            </div>
        </div>
    </div>
</main>

<!-- Footer -->
<footer class="border-t border-dark-border py-6 px-4 mt-8">
    <div class="max-w-6xl mx-auto text-center">
        <p class="text-text-muted text-sm">
            UC Davis Health ‚Ä¢ Department of Anesthesiology & Pain Medicine
        </p>
        <p class="text-text-muted text-xs mt-1">
            CA3 Journal Club Module
        </p>
    </div>
</footer>

<script>
    // Tab functionality
    document.querySelectorAll('.tab-btn').forEach(btn => {
        btn.addEventListener('click', () => {
            document.querySelectorAll('.tab-btn').forEach(b => b.classList.remove('active'));
            btn.classList.add('active');

            const tabId = btn.dataset.tab;
            document.querySelectorAll('.tab-content').forEach(content => {
                content.classList.remove('active');
            });
            document.getElementById(tabId).classList.add('active');
        });
    });

    // Quiz functionality
    const explanations = {
        0: { correct: 'Correct! The Apfel study demonstrated that antiemetic effects are additive‚Äîeach agent provides consistent, predictable benefit.', incorrect: 'The Apfel study specifically showed additive effects (1+1=2), not synergistic.' },
        1: { correct: 'Correct! Each antiemetic intervention provided approximately 26% relative risk reduction.', incorrect: 'The study found approximately 26% RRR per antiemetic intervention.' },
        2: { correct: 'Correct! Palonosetron is a newer second-generation 5-HT3 antagonist not available when Apfel conducted the trial.', incorrect: 'Palonosetron was not studied‚ÄîApfel used ondansetron as the 5-HT3 antagonist.' },
        3: { correct: 'Correct! With only 91 patients, the study was severely underpowered to detect the expected ~26% RRR.', incorrect: 'The primary limitation was insufficient sample size (n=91).' },
        4: { correct: 'Correct! The aprepitant group received 8mg dexamethasone versus 4mg in the placebo group.', incorrect: 'The differential dexamethasone dosing (8mg vs 4mg) confounds the results.' },
        5: { correct: 'Correct! Ondansetron + dexamethasone is cost-effective for nearly all patients with combined cost under $2.', incorrect: 'Ondansetron + dexamethasone was identified as almost always cost-effective.' },
        6: { correct: 'Correct! CA-3 residents expressed limited familiarity with droperidol and haloperidol use.', incorrect: 'Butyrophenones (droperidol/haloperidol) were identified as underutilized.' },
        7: { correct: 'Correct! The factorial design included 6 treatment variables, creating 64 possible combinations.', incorrect: 'Apfel\'s factorial design included 6 treatment variables.' },
        8: { correct: 'Correct! While outcome assessors were blinded, intra-operative anesthesia clinicians were not.', incorrect: 'The limitation was that intra-operative clinicians were not blinded.' },
        9: { correct: 'Correct! Caution is warranted when multiple antiemetics are already in use due to potential ceiling effects.', incorrect: 'Be most cautious when multiple antiemetics have already been implemented.' }
    };

    let score = 0;
    let answered = new Set();

    document.querySelectorAll('.quiz-option').forEach(option => {
        option.addEventListener('click', function() {
            const question = this.closest('.quiz-question');
            const questionIndex = Array.from(document.querySelectorAll('.quiz-question')).indexOf(question);

            if (answered.has(questionIndex)) return;

            const correctAnswer = question.dataset.correct;
            const selectedAnswer = this.dataset.option;
            const feedback = question.querySelector('.feedback');
            const points = parseInt(question.dataset.points);

            answered.add(questionIndex);
            this.classList.add('selected');

            question.querySelectorAll('.quiz-option').forEach(opt => {
                opt.style.pointerEvents = 'none';
                if (opt.dataset.option === correctAnswer) {
                    opt.classList.add('correct');
                } else if (opt.dataset.option === selectedAnswer && selectedAnswer !== correctAnswer) {
                    opt.classList.add('incorrect');
                }
            });

            feedback.classList.remove('hidden');
            if (selectedAnswer === correctAnswer) {
                score += points;
                feedback.className = 'feedback mt-4 p-3 rounded-lg text-sm bg-accent-green/20 text-accent-green border border-accent-green/30';
                feedback.innerHTML = `<strong>‚úì</strong> ${explanations[questionIndex].correct}`;
            } else {
                feedback.className = 'feedback mt-4 p-3 rounded-lg text-sm bg-accent-red/20 text-accent-red border border-accent-red/30';
                feedback.innerHTML = `<strong>‚úó</strong> ${explanations[questionIndex].incorrect}`;
            }

            document.getElementById('score').textContent = score;
        });
    });

    function resetQuiz() {
        score = 0;
        answered.clear();
        document.getElementById('score').textContent = '0';

        document.querySelectorAll('.quiz-question').forEach(question => {
            question.querySelectorAll('.quiz-option').forEach(opt => {
                opt.classList.remove('selected', 'correct', 'incorrect');
                opt.style.pointerEvents = 'auto';
            });
            question.querySelector('.feedback').classList.add('hidden');
        });
    }
</script>
</body>
</html>